Klingman & Associates LLC decreased its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 1.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 10,268 shares of the company’s stock after selling 124 shares during the period. Klingman & Associates LLC’s holdings in Procter & Gamble were worth $1,721,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Patrick M Sweeney & Associates Inc. increased its position in Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after buying an additional 59 shares in the last quarter. Lakeridge Wealth Management LLC increased its position in Procter & Gamble by 0.6% during the 4th quarter. Lakeridge Wealth Management LLC now owns 10,807 shares of the company’s stock valued at $1,812,000 after buying an additional 60 shares in the last quarter. Valued Wealth Advisors LLC increased its position in Procter & Gamble by 11.2% during the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock valued at $105,000 after buying an additional 61 shares in the last quarter. Colton Groome Financial Advisors LLC increased its position in Procter & Gamble by 3.2% during the 4th quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company’s stock valued at $334,000 after buying an additional 62 shares in the last quarter. Finally, Tevis Investment Management boosted its stake in Procter & Gamble by 0.6% during the 4th quarter. Tevis Investment Management now owns 11,633 shares of the company’s stock valued at $1,950,000 after purchasing an additional 65 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Price Performance
NYSE PG opened at $165.34 on Wednesday. The company has a market capitalization of $387.70 billion, a PE ratio of 26.33, a price-to-earnings-growth ratio of 3.66 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The business’s fifty day moving average is $166.21 and its 200 day moving average is $169.46. The Procter & Gamble Company has a fifty-two week low of $153.52 and a fifty-two week high of $180.43.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Investors of record on Friday, January 24th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 annualized dividend and a yield of 2.43%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.17%.
Wall Street Analyst Weigh In
Several analysts have commented on the company. Royal Bank of Canada reiterated a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Thursday, January 23rd. Wells Fargo & Company increased their target price on Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a research note on Thursday, January 23rd. JPMorgan Chase & Co. cut their target price on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. DA Davidson reiterated a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a research note on Thursday, January 23rd. Finally, UBS Group cut their target price on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Eight research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $180.53.
Check Out Our Latest Report on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the firm’s stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the sale, the insider now directly owns 172,814 shares in the company, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 151,097 shares of company stock valued at $25,635,076 over the last ninety days. 0.18% of the stock is currently owned by company insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Investing in Construction Stocks
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Where to Find Earnings Call Transcripts
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.